About Neela Patel
Neela Patel is a chief business officer at Bonum Therapeutics.
Neela Patel first appears on SEC filings in 2021.
Experience
This experience comes from Neela Patel's profile and from SEC filings. For roles taken from filings, the years are when the filings name Neela Patel in the role, so the role may have started earlier or lasted longer.
IN
Infinimmune Current
Board Member
2024 – Present
Bonum Therapeutics, Inc. Current
Chief Business Officer
CBO (2022 – Present)
2021 – Present · Seattle, WA
Develops targeted protein medicines for people with cancer.
MS
MEDIC Life Sciences Current
Executive Advisor
2021 – Present
GI
Good Therapeutics, Inc.
Chief Business Development Officer
2021 – 2022
SG
Seattle Genetics
Executive Director of Corporate Development
2016 – 2021
AB
AbbVie
Director, Search and Evaluation (Licensing)
2013 – 2016
AL
Abbott Laboratories
Director, Global External Research
2009 – 2013
PP
Poniard Pharmaceuticals
Director, Preclinical and Translational Medicine
2006 – 2009
GE
Genentech
Assoc Director, Product Portfolio Management
2003 – 2006
SP
SUGEN/Pharmacia
Associate Director, Discovery Biology
2000 – 2003
DI
DNAX Research Institute
Postdoctoral Fellow
1993 – 1996
Key Colleagues at Startups
The people Neela Patel works with at each company, as listed on that company's latest Form D.
Bonum Therapeutics, Inc. · Form D, Apr 17, 2026
Samuel Bjork
Executive Chair
Monique Schiersing
Senior Investment Director, Roche Venture
JM
John McKearn
Director
Diane Hollenbaugh
Chief Scientific Officer
Samuel Blackman
Independent Director
John Mulligan
Chief Executive Officer and director
Karl Handelsman
Founder & Managing Partner, Codon Capital, director
NW
Nicholas Walrod
Director
MM
Mitchell Mutz
Independent Director
Gaurav Aggarwal
Managing Partner, Vivo Capital and director